Jefferies Group’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-108,300
Closed -$1.68M 2207
2020
Q1
$1.68M Sell
108,300
-3,700
-3% -$79.5K 0.02% 765
2019
Q4
$2.75M Buy
+112,000
New +$1.66M 0.02% 853

Other funds holding EPZM

Jefferies Group's EPZM Position: Q2 2021 in Review

Jefferies Group sold out of Epizyme, Inc (EPZM) in Q2 2021, closing a stake of 22,828 shares — an estimated $199K sold.

Jefferies Group first reported a position in EPZM in Q4 2018 and held it in 7 quarters. The position peaked at $505K in Q2 2019. 126 funds tracked by Wall St. Rank hold EPZM as of Q2 2021.

  • Jefferies Group reported no remaining Epizyme, Inc position as of Q2 2021 after selling out during the quarter.
  • Jefferies Group sold 22,828 Epizyme, Inc shares in Q2 2021, an estimated $199K.
  • Jefferies Group first reported a position in Epizyme, Inc in Q4 2018 and held it in 7 quarters.
  • Jefferies Group's Epizyme, Inc position peaked at $505K in Q2 2019.
  • 126 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2021.

Based on Jefferies Group's 13F filing for Q2 2021, filed 16 Aug 2021.